Overview
After completing medical school in Nepal, Dr Thapa pursued training in Internal Medicine at Oakland University William Beaumont Hospital. Inspired by the complexity of oncology and the opportunity to apply latest research to patient care, she completed a fellowship in Hematology and Oncology at Moffitt Cancer Center. She is dedicated to caring for patients with all types of cancer and committed to supporting both patients and their families through every stage of diagnosis and treatment. She values working in a collaborative environment alongside a strong multidisciplinary team and dedicated support staff to deliver the best possible care. She relocated from Florida to the Pacific Northwest to be closer to family and to embrace the region’s natural beauty and active outdoor lifestyle.
Dr. Thapa is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. Her top areas of expertise are Budd-Chiari Syndrome, Waldenstrom Macroglobulinemia, Thrombocytopenia, and Splenomegaly.
Her clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of HELLP Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- POS
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
751 Northeast Blakely Drive, 0, Issaquah, WA 98029
751 Northeast Blakely Drive, Suite 1090, Issaquah, WA 98029
Additional Areas of Focus
Dr. Thapa has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Pacific Medical Centers Specialty Care - Renton
I want every patient to be treated like I would like to be treated myself. Dr. Barzdins' medical interests include: implementation of anonymized patient data sharing system as a promising tool in the war on cancer. Dr. Barzdins is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. His top areas of expertise are Agranulocytosis, Chronic Familial Neutropenia, Severe Congenital Neutropenia, and B-Cell Lymphoma.
The Polyclinic Madison Center - Oncology & Hematology
My philosophy is to consider the patient a partner in health care and to involve him/her in discussions and decisions regarding treatment and prevention of disease. Dr. Li is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. His top areas of expertise are Aase Syndrome, Metachondromatosis, Syndactyly Cenani Lenz Type, and X-Linked Severe Combined Immunodeficiency.
Center For Blood Disorders And Stem Cell Transplantation
Swathi Namburi, MD, is a hematologist who specializes in treating a variety of blood cancer and blood disorders. Her clinical research interests include multiple myeloma and novel immunotherapy approaches for blood cancers. Dr. Namburi is part of the Center for Blood Disorders and Cellular Therapy at the Swedish Cancer Institute. She provides full-spectrum care for her patients. This includes initial consultation and diagnosis, treatment to help achieve remission, consideration and enrollment onto clinical trials open through Providence/Swedish health care, and long-term management and survivorship related care. She oversees her patients through CAR-T cell therapy and autologous stem cell transplantation as these needs come up during various phases of treatment. Dr. Namburi completed a fellowship in hematology/oncology at the University of Pittsburgh Medical Center. She completed her residency at the George Washington University Medical Center in DC, and prior to that attended medical school at Rutgers/UMDNJ in New Brunswick, NJ near to where she grew up in East Brunswick, NJ. She is board certified in internal medicine, medical oncology, and hematology. She can communicate in several languages including Telugu, Hindi, Spanish, and French and she liberally receives help from Swedish’s wonderful in-person medical translators. Dr. Namburi has been practicing in the Seattle-Tacoma region since 2018. She is a board member of the Washington State Medical Oncology Society and participates in the annual Washington State Medical Association meetings to help support state initiatives that will help our patients with cancer have access to excellent care and treatment. She regularly attends and presents her work at national and international hematology conferences. Dr. Namburi is rated as an Advanced provider by MediFind in the treatment of HELLP Syndrome. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Budd-Chiari SyndromeDr. Thapa isExperienced. Learn about Budd-Chiari Syndrome.
- Waldenstrom MacroglobulinemiaDr. Thapa isExperienced. Learn about Waldenstrom Macroglobulinemia.